The In-vivo Services group of Vivo Bio Tech provides preclinical testing services in rodents/non-rodents, and canines for the evaluation of toxicity, pharmacological properties, ADME & PK properties of drug candidates in early stage development process. Our in-vivo experts have many years of expertise in drug discovery and development across all major therapeutic areas and can provide consultancy for clients in their drug discovery and development program, and suggest in exploring preclinical research options.
Further, our ADME experts consistently quantify and interpret results to put your IND-enabling programs on the fast track. We offer various in-vitro ADME to support your drug development program.
Our group is capable of carrying out below listed Pre-IND studies required for Phase-I studies and Post-IND studies required for NDA submission.
Pre-IND Studies Required for Phase I Trials
Post-IND Studies Required for an NDA
Expertise is available for carrying out toxicity studies through routes of administration –
We offer testing services across all standard test systems, which include –
Plans are ahead for providing commercial breeding services. Anticipated start date Q3+’10
Our scientists have expertise in development of various animal models and can further conduct testing services on these animal models as per the client’s requirement. Few of these animal models include, but not limited to